Results 41 to 50 of about 21,746 (148)

A case of bizarre posttransplant anti-glomerular basement membrane disease

Central European Journal of Immunology, 2019
The non-collagenous (NC1) domain of 3 and 5 chains of type IV collagen are eminent targets of abnormal immune response in anti-glomerular basement membrane (anti-GBM) disease, which can be diagnosed by the presence of strong linear IgG staining along ...
Anna Olewicz-Gawlik, Jan Żeromski, Monika Świerczewska, Ilona Idasiak-Piechocka, Magdalena Pawlik, Dorota Sikorska, Husam Samara, Andrzej Oko, Jan Sikora, Grzegorz Dworacki   +9 more
doaj   +1 more source

Temporal Clustering of Antiglomerular Basement Membrane Disease in COVID-19 Pandemic: A Case Series

International Journal of Nephrology and Renovascular Disease, 2021
Rakesh Sebastian, Jegan Arunachalam, Manorajan Rajendran Department of Nephrology, Government Rajaji Hospital, Madurai Medical College, Madurai, Tamil Nadu, IndiaCorrespondence: Jegan ArunachalamDepartment of Nephrology, Government Rajaji Hospital ...
Sebastian R, Arunachalam J, Rajendran M
doaj  

A case of aggressive atypical anti-GBM disease complicated by CMV pneumonitis

BMC Nephrology, 2019
Background Anti-glomerular basement membrane (anti-GBM) disease is characterized by circulating IgG glomerular basement membrane antibodies and is clinically expressed as a rapidly progressive crescentic glomerulonephritis (GN), with 30–60% of patients ...
Barbora Sporinova, Susanna A. McRae, Daniel A. Muruve, Marvin J. Fritzler, Samih H. Nasr, Alex C. Chin, Hallgrimur Benediktsson   +6 more
doaj   +1 more source

Anti-glomerular basement membrane disease: A clinicomorphological study of 16 cases

Indian Journal of Pathology and Microbiology, 2020
Introduction: Antiglomerular basement membrane disease manifests as rapidly progressive glomerulonephritis and alveolar hemorrhage. It encompasses 10–15% of crescentic glomerulonephritis and is associated with poor outcome.
Srinivasrao Vavilapalli, Nishika Madireddy, Megha S Uppin, Karthik Kalidindi, Swarnalatha Gudithi, Gangadhar Taduri, Sree Bhushan Raju   +6 more
doaj   +1 more source

Anti–Glomerular Basement Membrane Disease after Alemtuzumab

New England Journal of Medicine, 2008
To the Editor: Alemtuzumab (Campath-1H) is a humanized anti-CD52 monoclonal antibody, the administration of which causes profound B- and T-lymphocyte depletion. It is licensed for use in the treatment of chronic lymphocytic leukemia, and it is increasingly used in the treatment of autoimmune diseases (particularly multiple sclerosis) and as an ...
Clatworthy, MR, Wallin, E, Jayne, DR
openaire   +2 more sources

Difficulties in Goodpasture's syndrome diagnosing [PDF]

Терапевтический архив, 2019
The article analyzes the diagnosis and treatment of anti-GBM antibody disease (Goodpasture's syndrome) - a rare, severe progressive disease, associated with anti-glomerular basement membrane antibody-induced pulmonary hemorrhage and glomerulonephritis ...
V I Podzolkov, G K Makhnach, T I Ishina, A B Ponomarev, I D Medvedev   +4 more
doaj   +1 more source

Multiple occurrences of membranous nephropathy complicated with anti-glomerular basement membrane antibody and anti-neutrophil cytoplasm antibody double-negative crescentic formation since the COVID-19 pandemic: A case series

Journal of International Medical Research
There has been an unusual increase in the incidence of anti-glomerular basement membrane disease, anti-neutrophil cytoplasm antibody (ANCA)-associated vasculitis, and double-positive cases since the coronavirus disease 2019 (COVID-19) pandemic.
Shuang Yuan, Chao Li, ZhiBo Guo, Guang Yang, LiHong Zhang, Tao Wang   +5 more
doaj   +1 more source

Clinical and immunologic characteristics of Japanese patients with anti-glomerular basement membrane disease: case reports and literature review

Renal Replacement Therapy, 2021
Background Clinical studies of anti-glomerular basement membrane (GBM) disease were limited because of the low incidence. We aimed to report the characteristics, treatments, and outcomes of patients with anti-GBM disease at a tertiary reference medical ...
Yoshinosuke Shimamura, Takuto Maeda, Koki Abe, Yayoi Ogawa, Hideki Takizawa   +4 more
doaj   +1 more source

Plasma exchange in anti-glomerular basement membrane disease

La Presse Médicale, 2019
Anti-glomerular basement membrane (GBM) disease is a rare autoimmune vasculitis characterised by antibodies directed against the non collagenous (NC1) domain of the α3 chain of type 4 collagen (α3(IV)NC1). Clinical features are typically of a rapidly progressive glomerulonephritis (RPGN) with or without pulmonary haemorrhage.
Prendecki, M, Pusey, C
openaire   +4 more sources

Antimitochondrial autoantibodies in anti-glomerular basement membrane disease

Clinical and Experimental Immunology, 1993
SUMMARYAnti-glomerular basement membrane (GBM) disease is characterized by the production of an autoantibody with very restricted specificity, with no evidence of polyclonal B cell activation. It was therefore surprising to find that in a solid-phase ELISA a proportion of anti-GBM sera showed significant binding to pyruvate dehydrogenase (PDH), a ...
J B, Marriott, D B, Oliveira
openaire   +3 more sources